Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rodoniki, Iosifidou"'
Autor:
Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgios N. Tsaousis, Georgia Pepe, Dimitra Bouzarelou, Nikolaos Tsoulos, Athanasios Papathanasiou, Dimitrios Ziogas, Vassileios Venizelos, Christos Markopoulos, Rodoniki Iosifidou, Sofia Karageorgopoulou, Stylianos Giassas, Ioannis Natsiopoulos, Konstantinos Papazisis, Maria Vasilaki-Antonatou, Amanta Psyrri, Anna Koumarianou, Dimitrios Matthaios, Eleni Zairi, Alexandru Blidaru, Eugeniu Banu, Dan Corneliu Jinga, Şahin Laçin, Mustafa Özdoğan, Eirini Papadopoulou, George Nasioulas
Publikováno v:
Cancers, Vol 15, Iss 21, p 5218 (2023)
Background: Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In order to identify individuals at risk in a cost-efficient manner, family members of individuals carrying pathogenic alt
Externí odkaz:
https://doaj.org/article/7625acdfb9c04f86a13932062843f819
Autor:
Georgios N. Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi, Anna Koumarianou, Christos Markopoulos, Konstantinos Papazisis, Vasileios Venizelos, Ioannis Xanthakis, Grigorios Xepapadakis, Eugeniu Banu, Dan Tudor Eniu, Serban Negru, Dana Lucia Stanculeanu, Andrei Ungureanu, Vahit Ozmen, Sualp Tansan, Mehmet Tekinel, Suayib Yalcin, George Nasioulas
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
Abstract Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause
Externí odkaz:
https://doaj.org/article/dc43f140d22c4f09805d95f871555460
Publikováno v:
In European Journal of Surgical Oncology February 2024 50(2)
Autor:
Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Georgia Pepe, Eirini Papadopoulou, Georgios N Tsaousis, Despina Apostolopoulou, Angeliki Meintani, Vassileios Venizelos, Christos Markopoulos, Rodoniki Iosifidou, Sofia Karageorgopoulou, Christos Christodoulou, Ioannis Natsiopoulos, Konstantinos Papazisis, Maria Vasilaki-Antonatou, Eleftherios Kabletsas, Amanta Psyrri, Stylianos Giassas, Dimitrios Ziogas, Efthalia Lalla, Anna Koumarianou, Christos Papadimitriou, Vahit Ozmen, Sualp Tansan, Kerim Kaban, Tahsin Ozatlı, Dan Tudor Eniu, Angelica Chiorean, Alexandru Blidaru, George Nasioulas
Publikováno v:
Cancer Research. 82:P2-09
Background: Breast cancer is the most frequently diagnosed cancer in women and about 10% of breast cancer cases are hereditary. BRCA1 and BRCA2 are the genes most frequently associated with Hereditary Breast Cancer, although there are numerous other
Autor:
Kerim Kaban, Sonia Maravelaki, Vahit Ozmen, Konstantinos Papazisis, Konstantinos Agiannitopoulos, Maria Vasilaki-Antonatou, Christos Markopoulos, Sofia Karageorgopoulou, Stavroula Kampouri, Vassileios Venizelos, Christos Christodoulou, Rodoniki Iosifidou, Georgios N. Tsaousis, Ioannis Natsiopoulos, Georgia Pepe, Athanassios Fassas, Eirini Papadopoulou, Dan Tudor Eniu, Sualp Tansan, George Nasioulas, Angelica Chiorean
Publikováno v:
Cancer Genomics Proteomics
Background Classification of splicing variants (SVs) in genes associated with hereditary cancer is often challenging. The aim of this study was to investigate the occurrence of SVs in hereditary cancer genes and the clinical utility of RNA analysis.
Autor:
GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN, GEORGE NASIOULAS
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present data that demonstrate the different levels of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17928cee2350acf8044f319ac3d2bec4
https://europepmc.org/articles/PMC8717958/
https://europepmc.org/articles/PMC8717958/
Autor:
Ourania Katopodi, George Nasioulas, Stavroula Kampouri, Georgia Pepe, Rodoniki Iosifidou, Dan Tudor Eniu, Eirini Papadopoulou, Anna Koumarianou, Christos Markopoulos, Mehmet Tekinel, Serban Negru, Ioannis Xanthakis, V. Venizelos, Grigorios Xepapadakis, Sualp Tansan, Vahit Ozmen, Konstantinos Papazisis, Suayib Yalcin, Georgios N. Tsaousis, Nikolaos Diamantopoulos, E Banu, Theofanis Floros, Dana Lucia Stanculeanu, Konstantinos Agiannitopoulos, A Ungureanu, Angela Apessos
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
BMC Cancer
BMC Cancer
Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer
Autor:
Tsaousis, Georgios, Papadopoulou, Eirini, Apessos, Angela, Agiannitopoulos, Konstantinos, Pepe, Georgia, Kampouri, Stavroula, Diamantopoulos, Nikolaos, Floros, Theofanis, Rodoniki Iosifidou, Katopodi, Ourania, Koumarianou, Anna, Markopoulos, Christos, Papazisis, Konstantinos, Venizelos, Vasileios, Xanthakis, Ioannis, Xepapadakis, Grigorios, Banu, Eugeniu, Eniu, Dan, Negru, Serban, Stanculeanu, Dana, Ungureanu, Andrei, Ozmen, Vahit, Sualp Tansan, Tekinel, Mehmet, Suayib Yalcin, Nasioulas, George
Table S4. Individuals with 2 Pathogenic/ Likely Pathogenic variants. (PDF 557 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104f2326e008ea1fb8b770f32f0b9b3f
Autor:
Tsaousis, Georgios, Papadopoulou, Eirini, Apessos, Angela, Agiannitopoulos, Konstantinos, Pepe, Georgia, Kampouri, Stavroula, Diamantopoulos, Nikolaos, Floros, Theofanis, Rodoniki Iosifidou, Katopodi, Ourania, Koumarianou, Anna, Markopoulos, Christos, Papazisis, Konstantinos, Venizelos, Vasileios, Xanthakis, Ioannis, Xepapadakis, Grigorios, Banu, Eugeniu, Eniu, Dan, Negru, Serban, Stanculeanu, Dana, Ungureanu, Andrei, Ozmen, Vahit, Sualp Tansan, Tekinel, Mehmet, Suayib Yalcin, Nasioulas, George
Figure S1. Mutation types for pathogenic/likely pathogenic variants and VUS among the 1197 individuals tested with a hereditary cancer panel A. Mutation types for the 161 unique pathogenic/likely pathogenic variants identified in 264 individuals. B.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa45060b0b2731e8c51dfce6b4ad85c
Autor:
Tsaousis, Georgios, Papadopoulou, Eirini, Apessos, Angela, Agiannitopoulos, Konstantinos, Pepe, Georgia, Kampouri, Stavroula, Diamantopoulos, Nikolaos, Floros, Theofanis, Rodoniki Iosifidou, Katopodi, Ourania, Koumarianou, Anna, Markopoulos, Christos, Papazisis, Konstantinos, Venizelos, Vasileios, Xanthakis, Ioannis, Xepapadakis, Grigorios, Banu, Eugeniu, Eniu, Dan, Negru, Serban, Stanculeanu, Dana, Ungureanu, Andrei, Ozmen, Vahit, Sualp Tansan, Tekinel, Mehmet, Suayib Yalcin, Nasioulas, George
Table S1. Frequency of Pathogenic and Likely Pathogenic variants among genes. (PDF 539 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4020549ad6ad2016d00117687ed93b